-
公开(公告)号:US20190112656A1
公开(公告)日:2019-04-18
申请号:US16088596
申请日:2017-03-25
IPC分类号: C12Q1/6876 , A61Q19/08 , A23L33/18 , A61K31/185 , A61K8/46 , C12Q1/6809 , C12Q1/6825
摘要: The present invention provides a method for measuring senescence of a test subject, including a step of measuring a level of taurine modification of mitochondrial tRNALeu(UUR) in a biological sample isolated from a test subject, by a reverse transcription reaction from a primer with the tRNALeu(UUR) as a template. In addition, the present invention also provides a senescence determining drug containing a primer containing a base sequence consisting of 10-25 bases and complementary to the mitochondrial tRNALeu(UUR). Furthermore, the present invention also provides a senescence determining kit containing a primer containing a base sequence consisting of 10-25 bases and complementary to the mitochondrial tRNALeu(UUR) and a reverse transcriptase. Moreover, the present invention also provides an agent for improving a taurine modification rate of mitochondrial tRNALeu(UUR), containing taurine as an active ingredient.
-
公开(公告)号:US20180251760A1
公开(公告)日:2018-09-06
申请号:US15759305
申请日:2016-09-16
IPC分类号: C12N15/113
CPC分类号: C12N15/113 , A61K31/7088 , C12N15/1136 , C12N2310/11 , C12N2310/31 , C12N2310/32 , C12N2310/3233 , C12N2310/3519 , C12N2320/33
摘要: There has been a demand for a novel antisense nucleic acid or the like capable of inhibiting myostatin at the mRNA level.The present invention provides a specific antisense oligomer which allows exon 2 skipping in the myostatin gene or induces degradation of mRNA of the myostatin gene.
-